Wisconsin DHS Pauses Administration of Johnson & Johnson COVID-19 Vaccine

Vaccinators instructed to stop administering Johnson & Johnson vaccine

News Release For Immediate Release April 13, 2021 Contact: Jennifer Miller/Elizabeth Goodsitt 608-266-1683 Wisconsin DHS Pauses Administration of Johnson & Johnson COVID-19 Vaccine  Vaccinators instructed to stop administering Johnson & Johnson vaccine The Wisconsin Department of Health Services (DHS) is instructing Wisconsin vaccine providers to stop administering the Johnson & Johnson COVID-19 vaccine due to a federal review of adverse side effects reported. The Centers for Disease Control (CDC) and U.S. Food and Drug Administration (FDA) issued a statement saying six cases of a rare and severe type of blood clot called cerebral venous sinus thrombosis have been reported in the U.S. out of 6.8 million Johnson & Johnson vaccine doses given. "We are pausing administration of the Johnson & Johnson vaccine out of an abundance of caution. At this time, these adverse events appear to be extremely rare," said DHS Secretary-designee Karen Timberlake. "Vaccine providers should not administer the Johnson & Johnson vaccine at this time, and should hold on to the vaccine until federal review has been completed." View the entire news release. You signed up to receive Wisconsin Department of Health Services News Releases. If you have a question, do not reply directly to this message. Email the Communications Team or call the media line at 608-266-1683.

Stay Connected with the Wisconsin Department of Health Services     Manage Preferences | Subscriber Help

---

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: Wisconsin Department of Health Services · 1 West Wilson Street · Madison, WI 53703